We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00131612
Recruitment Status : Terminated (did not apply for ethics renewal)
First Posted : August 19, 2005
Last Update Posted : February 26, 2016
Information provided by (Responsible Party):
AHS Cancer Control Alberta

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2005
  Study Completion Date : January 2013